Issy les Moulineaux, France

Maïa Chanrion

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Maïa Chanrion: Innovator in Medicinal Chemistry

Introduction

Maïa Chanrion is a prominent inventor based in Issy les Moulineaux, France, known for his significant contributions to medicinal chemistry. With an impressive portfolio of 9 patents, Chanrion has focused on developing innovative compounds aimed at combating severe health conditions, particularly cancer.

Latest Patents

Among his latest patents, Chanrion has made remarkable advancements with “Substituted piperidines as inhibitors of ubiquitin specific protease 7 - Compounds of formula (I): wherein R, R, R, B, W, Z, m and n are as defined in the description.” This invention showcases novel chemical compounds that could potentially hinder cancer progression. Another significant patent is “Substituted piperidines for the treatment of cancer - Compounds of formula (I): wherein R, R, R, n and W are as defined in the description,” which includes medicinal products that are useful for treating conditions requiring pro-apoptotic and/or anti-proliferative agents.

Career Highlights

Throughout his career, Chanrion has worked with reputable organizations such as Les Laboratoires Servier and Vernalis (R&D) Limited, where he contributed to research and development initiatives within the pharmaceutical sector. His roles have positioned him at the forefront of innovation in drug discovery.

Collaborations

Collaboration is key to Chanrion’s success in invention. He has worked closely with distinguished colleagues, including Olivier Geneste and András Kotschy, pooling their expertise to push the boundaries of medicinal chemistry further.

Conclusion

Maïa Chanrion's extensive patent portfolio and collaborative efforts illustrate his commitment to advancing the field of medicinal chemistry. His innovations not only reflect scientific excellence but also aim to provide therapeutic solutions for critical health challenges, particularly in the fight against cancer. As he continues to innovate, his work remains influential in shaping the future of pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…